1. Home
  2. BTOC vs NRSN Comparison

BTOC vs NRSN Comparison

Compare BTOC & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.31

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.49

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
NRSN
Founded
2020
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
14.2M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BTOC
NRSN
Price
$0.31
$0.49
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$8.50
AVG Volume (30 Days)
34.8K
238.8K
Earning Date
05-24-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$0.25
52 Week High
$1.45
$1.30

Technical Indicators

Market Signals
Indicator
BTOC
NRSN
Relative Strength Index (RSI) 56.41 42.47
Support Level $0.25 $0.39
Resistance Level $0.32 $0.74
Average True Range (ATR) 0.02 0.06
MACD 0.00 0.01
Stochastic Oscillator 74.92 67.23

Price Performance

Historical Comparison
BTOC
NRSN

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: